Pregnancy loss and thrombophilia: The elusive link

British Journal of Haematology

Volumn 157, Issue 5, 2012, Pages 529-542

  Bennett, Sarah A ^a   Bagot, Catherine N ^b   Arya, Roopen ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antiphospholipid syndrome; Fetal loss; Heparin; Miscarriage; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLACEBO; TINZAPARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; DISEASE ASSOCIATION; DRUG USE; HUMAN; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; THROMBOPHILIA;

ABORTION, SPONTANEOUS; ANTICOAGULANTS; FEMALE; FETAL DEATH; HUMANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; THROMBOPHILIA;

EID: 84860833822     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09112.x     Document Type: Review

References (123)

1. Ailus, K., Tulppala, M., Palosuo, T., Ylikorkala, O. & Vaarala, O. (1996) Antibodies to beta 2-glycoprotein I and prothrombin in habitual abortion. Fertility and Sterility, 66, 937-941.
2. Andree, H.A.M., Hermens, W.T., Hemker, H.C. & Willems, G.M. (1992) Displacement of factor Va by annexinV. In: Phospholipid Binding and Anticoagulant Action of Annexin V (ed. by H.A.M. Andree), pp. 73-85. Universitaire Pers Maastricht, Maastricht, the Netherlands.
3. Arnold, J., Holmes, Z., Pickering, W., Farmer, C., Regan, L. & Cohen, H. (2001) Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. British Journal of Haematology, 113, 911-914.
4. Awidi, A., Shannak, M., Bseiso, A., Kailani, M.A., Omar, N., Anshasi, B. & Sakarneh, N. (1999) High prevalence of factor V Leiden in healthy Jordanian Arabs. Thrombosis and Haemostasis, 81, 582-584.
5. Bates, S.M., Greer, I.A., Middeldorp, S., Veenstra, D.L., Prabulos, A.M. & Vandvik, P.O. (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e691S-e736S.
6. Branch, W. (2011) Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010. Lupus, 20, 158-164.
7. Brenner, B., Hoffman, R., Carp, H., Dulitsky, M. & Younis, J. (2005) Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis, 3, 227-229.
8. Brigham, S.A., Conlon, C. & Farquharson, R.G. (1999) A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Human Reproduction, 14, 2868-2871.
9. Carp, H., Toder, V., Aviram, A., Daniely, M., Mashiach, S. & Barkai, G. (2001) Karyotype of the abortus in recurrent miscarriage. Fertility and Sterility, 75, 678-682.
10. Carp, H., Dolitzky, M. & Inbal, A. (2003) Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. Journal of Thrombosis and Haemostasis, 1, 433-438.
11. Clark, P. & Walker, I.D. (2001) The phenomenon known as acquired activated protein C resistance. British Journal of Haematology, 115, 767-773.
12. Clark, P., Brennand, J., Conkie, J.A., McCall, F., Greer, I.A. & Walker, I.D. (1998) Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thrombosis and Haemostasis, 79, 1166-1170.
13. Clark, P., Walker, I.D. & Greer, I. (1999) Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet, 353, 292-293.
14. Clark, P., Sattar, N., Walker, I.D. & Greer, I.A. (2001) The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thrombosis and Haemostasis, 85, 30-35.
15. Clark, P., Walker, I.D., Langhorne, P., Crichton, L., Thomson, A., Greaves, M., Whyte, S. & Greer, I.A. (2010) SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood, 115, 4162-4167.
16. Clifford, K., Rai, R. & Regan, L. (1997) Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Human Reproduction, 12, 387-389.
17. Coulam, C.B., Stephenson, M., Stern, J.J. & Clark, D.A. (1996) Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. American Journal of Reproductive Immunology, 33, 352-359.
18. Creagh, M.D. & Greaves, M. (1991) Lupus anticoagulant. Blood Reviews, 5, 162-167.
19. Creagh, M.D., Malia, R.G., Cooper, S.M., Smith, A.R., Duncan, S.L. & Greaves, M. (1991) Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. Journal of Clinical Pathology, 44, 45-47.
20. Dahlback, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
21. Dawood, F., Farquharson, R., Quenby, S. & Toh, C.H. (2003) Acquired activated protein C resistance may be a risk factor for recurrent fetal loss. Fertility and Sterility, 80, 649-650.
22. De Wolf, F., Carreras, L.O., Moerman, P., Vermylen, J., Van Assche, A. & Renaer, M. (1982) Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. American Journal of Obstetrics and Gynecology, 142, 829-834.
23. Dizon-Townson, D.S., Meline, L., Nelson, L.M., Varner, M. & Ward, K. (1997) Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. American Journal of Obstetrics and Gynecology, 177, 402-405.
24. van Dunne, F.M., Doggen, C.J., Heemskerk, M., Rosendaal, F.R. & Helmerhorst, F.M. (2005) Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Human Reproduction, 20, 802-806.
25. van Dunne, F.M., de Craen, A.J., Heijmans, B.T., Helmerhorst, F.M. & Westendorp, R.G. (2006) Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study. Human Reproduction, 21, 967-971.
26. Empson, M., Lassere, M., Craig, J. & Scott, J. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Systematic Review, (2), CD002859.
27. Faden, D., Tincani, A., Tanzi, P., Spatola, L., Lojacono, A., Tarantini, M. & Balestrieri, G. (1997) Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 73, 37-42.
28. Farquharson, R.G., Quenby, S. & Greaves, M. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology, 100, 408-413.
29. Fishman, P., Falach-Vaknine, E., Zigelman, R., Bakimer, R., Sredni, B., Djaldetti, M. & Shoenfeld, Y. (1993) Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. Journal of Clinical Investigation, 91, 1834-1837.
30. Folkeringa, N., Brouwer, J.L., Korteweg, F.J., Veeger, N.J., Erwich, J.J., Holm, J.P. & van der Meer, J. (2007) Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. British Journal of Haematology, 136, 656-661.
31. Franco, R.F. & Reitsma, P.H. (2001) Genetic risk factors of venous thrombosis. Human Genetics, 109, 369-384.
32. Franklin, R.D. & Kutteh, W.H. (2002) Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Human Reproduction, 17, 2981-2985.
33. Girardi, G., Redecha, P. & Salmon, J.E. (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nature Medicine, 10, 1222-1226.
34. Gopel, W., Ludwig, M., Junge, A.K., Kohlmann, T., Diedrich, K. & Moller, J. (2001) Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet, 358, 1238-1239.
35. Gorton, H.J., Warren, E.R., Simpson, N.A., Lyons, G.R. & Columb, M.O. (2000) Thromboelastography identifies sex-related differences in coagulation. Anesthesia and Analgesia, 91, 1279-1281.
36. Goswamy, R.K., Williams, G. & Steptoe, P.C. (1988) Decreased uterine perfusion-a cause of infertility. Human Reproduction, 3, 955-959.
37. Greer, I. (2003) Thrombophilia: implications for pregnancy outcome. Thrombosis Research, 109, 73-81.
38. Greer, I.A. & Nelson-Piercy, C. (2005) Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood, 106, 401-407.
39. Gris, J.C., Quere, I., Monpeyroux, F., Mercier, E., Ripart-Neveu, S., Tailland, M.L., Hoffet, M., Berlan, J., Daures, J.P. & Mares, P. (1999) Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thrombosis and Haemostasis, 81, 891-899.
40. Gris, J.C., Mercier, E., Quere, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.L., Dauzat, M. & Mares, P. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood, 103, 3695-3699.
41. Hassold, T. & Hunt, P. (2001) To err (meiotically) is human: the genesis of human aneuploidy. Nature Reviews Genetics, 2, 280-291.
42. Hatasaka, H.H. (1994) Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clinical Obstetrics and Gynecology, 37, 625-634.
43. Hellgren, M. & Blomback, M. (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecologic and Obstetric Investigation, 12, 141-154.
44. Hertig, A.T., Rock, J. & Adams, E.C. (1956) A description of 34 human ova within the first 17 days of development. American Journal of Anatomy, 98, 435-493.
45. Holmes, Z.R., Regan, L., Chilcott, I. & Cohen, H. (1999) The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. British Journal of Haematology, 105, 98-101.
46. Hundsdoerfer, P., Vetter, B., Stover, B., Bassir, C., Scholz, T., Grimmer, I., Monch, E., Ziemer, S., Rossi, R. & Kulozik, A.E. (2003) Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss. Thrombosis and Haemostasis, 90, 628-635.
47. Irani-Hakime, N., Tamim, H., Elias, G., Finan, R.R., Daccache, J.L. & Almawi, W.Y. (2000) High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean. Clinical Chemistry, 46, 134-136.
48. Isermann, B., Sood, R., Pawlinski, R., Zogg, M., Kalloway, S., Degen, J.L., Mackman, N. & Weiler, H. (2003) The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nature Medicine, 9, 331-337.
49. Jauniaux, E., Farquharson, R.G., Christiansen, O.B. & Exalto, N. (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction, 21, 2216-2222.
50. Jerrard-Dunne, P., Evans, A., McGovern, R., Hajat, C., Kalra, L., Rudd, A.G., Wolfe, C.D. & Markus, H.S. (2003) Ethnic differences in markers of thrombophilia: implications for the investigation of ischemic stroke in multiethnic populations: the South London Ethnicity and Stroke Study. Stroke, 34, 1821-1826.
51. Jivraj, S., Rai, R., Underwood, J. & Regan, L. (2006) Genetic thrombophilic mutations among couples with recurrent miscarriage. Human Reproduction, 21, 1161-1165.
52. Kaandorp, S.P., Goddijn, M., van der Post, J.A., Hutten, B.A., Verhoeve, H.R., Hamulyak, K., Mol, B.W., Folkeringa, N., Nahuis, M., Papatsonis, D.N., Buller, H.R., van der Veen, F. & Middeldorp, S. (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine, 362, 1586-1596.
53. Keeling, D., Mackie, I., Moore, G.W., Greer, I.A. & Greaves, M. (2012) Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology, 157, 47-58.
54. Kist, W.J., Janssen, N.G., Kalk, J.J., Hague, W.M., Dekker, G.A. & de Vries, J.I. (2008) Thrombophilias and adverse pregnancy outcome - a confounded problem! Thrombosis and Haemostasis, 99, 77-85.
55. Kovalevsky, G., Gracia, C.R., Berlin, J.A., Sammel, M.D. & Barnhart, K.T. (2004) Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Archives of Internal Medicine, 164, 558-563.
56. Krikun, G., Lockwood, C.J., Wu, X.X., Zhou, X.D., Guller, S., Calandri, C., Guha, A., Nemerson, Y. & Rand, J.H. (1994) The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta, 15, 601-612.
57. Kutteh, W.H. (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology, 174, 1584-1589.
58. Kutteh, W.H. (2002) Antiphospholipid syndrome in pregnancy. Obstetrics and Gynecology, 100, 1354; author reply 1355-1356.
59. Laskin, C.A., Spitzer, K.A., Clark, C.A., Crowther, M.R., Ginsberg, J.S., Hawker, G.A., Kingdom, J.C., Barrett, J. & Gent, M. (2009) Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Journal of Rheumatology, 36, 279-287.
60. Lay, A.J., Liang, Z., Rosen, E.D. & Castellino, F.J. (2005) Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities. Journal of Clinical Investigation, 115, 1552-1561.
61. Lee, R.M., Branch, D.W. & Silver, R.M. (2001) Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. American Journal of Obstetrics and Gynecology, 185, 748-753.
62. Lee, E.Y., Lee, C.K., Lee, T.H., Chung, S.M., Kim, S.H., Cho, Y.S., Yoo, B. & Moon, H.B. (2003) Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thrombosis Research, 111, 29-32.
63. Lieby, P., Poindron, V., Roussi, S., Klein, C., Knapp, A.M., Garaud, J.C., Cerutti, M., Martin, T. & Pasquali, J.L. (2004) Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood, 104, 1711-1715.
64. Lindqvist, P.G., Svensson, P. & Dahlback, B. (2006) Activated protein C resistance - in the absence of factor V Leiden - and pregnancy. Journal of Thrombosis and Haemostasis, 4, 361-366.
65. Lockwood, C. & Wendel, G. (2011) Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstetrics and Gynecology, 118, 730-740.
66. Makikallio, K., Tekay, A. & Jouppila, P. (1999) Yolk sac and umbilicoplacental hemodynamics during early human embryonic development. Ultrasound in Obstetrics and Gynecology, 14, 175-179.
67. Maybury, H., Waugh, J., Gornall, A. & Pavord, S.R. (2008) There is a return to non-pregnant coagulation parameters after four not six weeks postpartum following spontaneous vaginal delivery. Obstetric Medicine, 1, 92-94.
68. Miall, F.M., Deol, P.S., Barnes, T.A., Dampier, K., Watson, C.C., Oppenheimer, C.A., Pasi, K.J. & Pavord, S.R. (2005) Coagulation status and complications of pregnancy. Thrombosis Research, 115, 461-467.
69. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306.
70. Nash, M.J., Camilleri, R.S., Kunka, S., Mackie, I.J., Machin, S.J. & Cohen, H. (2004) The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. Journal of Thrombosis and Haemostasis, 2, 1077-1081.
71. Nelen, W.L.D.M., Blom, H.J., Steegers, E.A.P., den Heijer, M. & Eskes, T.K.A.B. (2000) Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertility and Sterility, 74, 1196-1199.
72. Nelson, S.M. & Greer, I.A. (2008) The potential role of heparin in assisted conception. Human Reproduction Update, 14, 623-645.
73. Noble, L.S., Kutteh, W.H., Lashey, N., Franklin, R.D. & Herrada, J. (2005) Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertility and Sterility, 83, 684-690.
74. Ogasawara, M., Aoki, K., Okada, S. & Suzumori, K. (2000) Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertility and Sterility, 73, 300-304.
75. Ogueh, O., Chen, M.F., Spurll, G. & Benjamin, A. (2001) Outcome of pregnancy in women with hereditary thrombophilia. International Journal of Gynaecology and Obstetrics, 74, 247-253.
76. Out, H.J., Kooijman, C.D., Bruinse, H.W. & Derksen, R.H. (1991) Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 41, 179-186.
77. Paidas, M.J., Ku, D.H., Lee, M.J., Manish, S., Thurston, A., Lockwood, C.J. & Arkel, Y.S. (2005) Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. Journal of Thrombosis and Haemostasis, 3, 497-501.
78. Patel, R.K., Ford, E., Thumpston, J. & Arya, R. (2003) Risk factors for venous thrombosis in the black population. Thrombosis and Haemostasis, 90, 835-838.
79. Patel, J.P., Patel, R.K., Graham Davies, J. & Arya, R. (2011) Prophylaxis with low-dose low molecular weight heparin during pregnancy and the puerperium - is it effective? Journal of Thrombosis and Haemostasis, 9, 1269-1271.
80. Pattison, N.S., Chamley, L.W., Birdsall, M., Zanderigo, A.M., Liddell, H.S. & McDougall, J. (2000) Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. American Journal of Obstetrics and Gynecology, 183, 1008-1012.
81. Pierangeli, S.S., Leader, B., Barilaro, G., Willis, R. & Branch, D.W. (2011) Acquired and inherited thrombophilia disorders in pregnancy. Obstetrics and Gynecology Clinics of North America, 38, 271-295, x.
82. Poindron, V., Berat, R., Knapp, A.M., Toti, F., Zobairi, F., Korganow, A.S., Chenard, M.P., Gounou, C., Pasquali, J.L., Brisson, A. & Martin, T. (2011) Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss. Journal of Thrombosis and Haemostasis, 9, 1937-1947.
83. Preston, F.E., Rosendaal, F.R., Walker, I.D., Briët, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., Pabinger, I., Legnani, C., Scharrer, I., Schulman, S. & van der Meer, F.J.M. (1996) Increased fetal loss in women with heritable thrombophilia. The Lancet, 348, 913-916.
84. Quere, I., Bellet, H., Hoffet, M., Janbon, C., Mares, P. & Gris, J.C. (1998) A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriage. Fertility and Sterility, 69, 152-154.
85. Rai, R. (2008) Immunological Testing and Interventions for Reproductive Failure. Royal College of Obstetricians and Gynaecologists Scientific Advisory Committee Paper 5. RCOG Press, London.
86. Rai, R. & Regan, L. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology, 100, 1354.
87. Rai, R.S., Regan, L., Clifford, K., Pickering, W., Dave, M., Mackie, I., McNally, T. & Cohen, H. (1995) Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Human Reproduction, 10, 2001-2005.
88. Rai, R., Clifford, K. & Regan, L. (1996) The modern preventative treatment of recurrent miscarriage. British Journal of Obstetrics and Gynaecology, 103, 106-110.
89. Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ, 314, 253-257.
90. Rai, R., Shlebak, A., Cohen, H., Backos, M., Holmes, Z., Marriott, K. & Regan, L. (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reproduction, 16, 961-965.
91. Rai, R., Tuddenham, E., Backos, M., Jivraj, S., El'Gaddal, S., Choy, S., Cork, B. & Regan, L. (2003) Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Human Reproduction, 18, 2540-2543.
92. Rand, J.H., Wu, X.X., Guller, S., Gil, J., Guha, A., Scher, J. & Lockwood, C.J. (1994) Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. American Journal of Obstetrics and Gynecology, 171, 1566-1572.
93. Rand, J.H., Wu, X.X., Andree, H.A., Lockwood, C.J., Guller, S., Scher, J. & Harpel, P.C. (1997) Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. New England Journal of Medicine, 337, 154-160.
94. Rees, D.C., Cox, M. & Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133-1134.
95. Regan, L., Backos, M. & Rai, R. (2011) The Investigation and Treatment of Couples with Recurrent First-Trimester and Second-Trimester Miscarriages. Royal College of Obstetricians and Gynaecologists Green-top guideline No.17. RCOG Press, London.
96. Rey, E., Kahn, S.R., David, M. & Shrier, I. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet, 361, 901-908.
97. Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. & Greer, I.A. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171-196.
98. Rodger, M.A. & Paidas, M. (2007) Do thrombophilias cause placenta-mediated pregnancy complications? Seminars in Thrombosis and Hemostasis, 33, 597-603.
99. Rosendaal, F.R., Doggen, C.J., Zivelin, A., Arruda, V.R., Aiach, M., Siscovick, D.S., Hillarp, A., Watzke, H.H., Bernardi, F., Cumming, A.M., Preston, F.E. & Reitsma, P.H. (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and Haemostasis, 79, 706-708.
100. Saha, P., Stott, D. & Atalla, R. (2009) Haemostatic changes in the puerperium '6 weeks postpartum' (HIP Study) - implication for maternal thromboembolism. BJOG, 116, 1602-1612.
101. de Saint Martin, L., Duchemin, J., Bohec, C., Couturaud, F., Mottier, D., Collet, M., Blouch, M.T. & Pasquier, E. (2011) Increased thrombin generation measured in the presence of thrombomodulin in women with early pregnancy loss. Fertility and Sterility, 95, 1813-1815 e1811.
102. Sakata, T., Okamoto, A., Mannami, T., Matsuo, H. & Miyata, T. (2004a) Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. Journal of Thrombosis and Haemostasis, 2, 528-530.
103. Sakata, T., Okamoto, A., Mannami, T., Tomoike, H. & Miyata, T. (2004b) Prevalence of protein S deficiency in the Japanese general population: the Suita Study. Journal of Thrombosis and Haemostasis, 2, 1012-1013.
104. Sanson, B.J., Lensing, A.W., Prins, M.H., Ginsberg, J.S., Barkagan, Z.S., Lavenne-Pardonge, E., Brenner, B., Dulitzky, M., Nielsen, J.D., Boda, Z., Turi, S., Mac Gillavry, M.R., Hamulyak, K., Theunissen, I.M., Hunt, B.J. & Buller, H.R. (1999) Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thrombosis and Haemostasis, 81, 668-672.
105. Sebire, N.J., Fox, H., Backos, M., Rai, R., Paterson, C. & Regan, L. (2002) Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Human Reproduction, 17, 1067-1071.
106. Siristatidis, C.S., Dodd, S.R. & Drakeley, A.J. (2011) Aspirin for in vitro fertilisation. Cochrane Database Systematic Review, (8), CD004832.
107. Sood, R., Zogg, M., Westrick, R.J., Guo, Y.H., Kerschen, E.J., Girardi, G., Salmon, J.E., Coughlin, S.R. & Weiler, H. (2007) Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. Journal of Experimental Medicine, 204, 1049-1056.
108. Steer, P.L. & Krantz, H.B. (1993) Thromboelastography and Sonoclot analysis in the healthy parturient. Journal of Clinical Anesthesia, 5, 419-424.
109. Stephenson, M.D., Awartani, K.A. & Robinson, W.P. (2002) Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Human Reproduction, 17, 446-451.
110. Stephenson, M.D., Ballem, P.J., Tsang, P., Purkiss, S., Ensworth, S., Houlihan, E. & Ensom, M.H. (2004) Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. Journal of Obstetrics and Gynaecology Canada, 26, 729-734.
111. Stern, J.J., Dorfmann, A.D., Gutierrez-Najar, A.J., Cerrillo, M. & Coulam, C.B. (1996) Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertility and Sterility, 65, 250-253.
112. Stirrat, G.M. (1990) Recurrent miscarriage. Lancet, 336, 673-675.
113. Stray-Pedersen, B. & Stray-Pedersen, S. (1984) Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. American Journal of Obstetrics and Gynecology, 148, 140-146.
114. Szecsi, P.B., Jorgensen, M., Klajnbard, A., Andersen, M.R., Colov, N.P. & Stender, S. (2010) Haemostatic reference intervals in pregnancy. Thrombosis and Haemostasis, 103, 718-727.
115. Tait, R.C., Walker, I.D., Perry, D.J., Islam, S.I., Daly, M.E., McCall, F., Conkie, J.A. & Carrell, R.W. (1994) Prevalence of antithrombin deficiency in the healthy population. British Journal of Haematology, 87, 106-112.
116. Toth, B., Vocke, F., Rogenhofer, N., Friese, K., Thaler, C.J. & Lohse, P. (2008) Paternal thrombophilic gene mutations are not associated with recurrent miscarriage. American Journal of Reproductive Immunology, 60, 325-332.
117. de Visser, M.C., Rosendaal, F.R. & Bertina, R.M. (1999) A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood, 93, 1271-1276.
118. Vora, S., Shetty, S. & Ghosh, K. (2008) Thrombophilic dimension of recurrent fetal loss in Indian patients. Blood Coagulation and Fibrinolysis, 19, 581-584.
119. Wang, X., Ma, Z. & Lin, Q. (2006) Inherited thrombophilia in recurrent spontaneous abortion among Chinese women. International Journal of Gynaecology and Obstetrics, 92, 264-265.
120. Warburton, D. & Fraser, F.C. (1964) Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. American Journal of Human Genetics, 16, 1-25.
121. Younis, J.S., Ohel, G., Brenner, B. & Ben-Ami, M. (1997) Familial thrombophilia-the scientific rationale for thrombophylaxis in recurrent pregnancy loss? Human Reproduction, 12, 1389-1390.
122. Zegers-Hochschild, F., Adamson, G.D., de Mouzon, J., Ishihara, O., Mansour, R., Nygren, K., Sullivan, E. & Vanderpoel, S. (2009) International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertility and Sterility, 92, 1520-1524.
123. Zivelin, A., Rosenberg, N., Faier, S., Kornbrot, N., Peretz, H., Mannhalter, C., Horellou, M.H. & Seligsohn, U. (1998) A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood, 92, 1119-1124.